Artal Group’s Spero Therapeutics SPRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-500,000	Closed	-$1M	–	131
2022 Q3	$1M	Hold	500,000	–	–	0.04%	109
2022 Q2	$371K	Hold	500,000	–	–	0.02%	127
2022 Q1	$4.35M	Hold	500,000	–	–	0.18%	84
2021 Q4	$8.01M	Hold	500,000	–	–	0.22%	73
2021 Q3	$9.21M	Hold	500,000	–	–	0.21%	77
2021 Q2	$6.98M	Hold	500,000	–	–	0.14%	105
2021 Q1	$7.36M	Hold	500,000	–	–	0.13%	102
2020 Q4	$9.7M	Sell	500,000 -100,000	-17%	-$1.94M	0.21%	81
2020 Q3	$6.7M	Buy	600,000 +54,960	+10%	+$613K	0.16%	76
2020 Q2	$7.37M	Sell	545,040 -30,960	-5%	-$419K	0.21%	72
2020 Q1	$4.65M	Buy	576,000 +76,000	+15%	+$614K	0.2%	65
2019 Q4	$4.81M	Sell	500,000 -40,000	-7%	-$385K	0.19%	63
2019 Q3	$5.72M	Hold	540,000	–	–	0.23%	59
2019 Q2	$6.22M	Sell	540,000 -60,000	-10%	-$691K	0.25%	61
2019 Q1	$7.69M	Hold	600,000	–	–	0.31%	50
2018 Q4	$3.69M	Hold	600,000	–	–	0.14%	52
2018 Q3	$6.31M	Buy	600,000 +250,000	+71%	+$2.63M	0.16%	46
2018 Q2	$5.14M	Hold	350,000	–	–	0.11%	48
2018 Q1	$4.99M	Hold	350,000	–	–	0.06%	46
2017 Q4	$4.11M	Buy	+350,000	New	+$4.11M	0.06%	44